
| Lenio Alvarenga Head of Clinical Operations - Brazil Roche Pharmaceuticals |
||
| Ronaldo Amaral Laboratório de Proliferação e Diferenciação Celular Universidade Federal do Rio de Janeiro |
Ronaldo graduated in Biology (Genetics) in Federal University of Rio de Janeiro in 2009. Nowadays he is a PhD student from the Morphological Sciences Program of the Biomedical Sciences Institute at the same university, where he also achieved a Masters degree in 2011. Ronaldo has experience in the Morphology area with emphasis on Cell Biology and... more › |
11.50am Drug Discovery: Wednesday, April 18, 2012
|
| Dr. Adriano Andricopulo Professor University of Sao Paulo - Brazil |
more › |
12.15pm Drug Discovery: Wednesday, April 18, 2012
|
| Edson Arakaki Medical Director at Andean Region Bayer Healthcare |
• 1982 – 1987 - Medicine, Universidade Estadual Paulista (UNESP). more › |
9am Pharma Trials: Wednesday, April 18, 2012
10am Pharma Trials: Wednesday, April 18, 2012
|
| Dr. Roberto Araujo Clinical Research Director RDO |
Dr. Roberto de Araújo is a geneticist with a PhD in Molecular Biology degree from Aberdeen University, UK. Throughout his time abroad, for some 22 years, Dr. Araújo has had the opportunity to work at the very best research facilities across the globe in several fields, ranging from the European Space Agency to Instituto Valenciano de Infertilidad... more › |
3.10pm Generics Congress: Wednesday, April 18, 2012
|
| Jader Baima Medical Genzyme |
more › |
12.25pm Pharma Trials: Wednesday, April 18, 2012
|
| Dirceu Barbano Director-Chairman ANVISA |
Graduado em Ciências Farmacêuticas pela PUC-Campinas. Foi professor na Faculdade de Farmácia da PUC-Campinas nos anos de 1990 e 2000. Foi Conselheiro do CFF em 1992. Diretor Vice-Presidente e depois Presidente do CRF do Estado de São Paulo, entre 1994 e 1997. Anos em que também foi dirigente sindical no Sindicato dos Farmacêuticos do Estado de São ... more › |
9.50am BioPharma: Tuesday, April 17, 2012
1.05pm BioPharma: Tuesday, April 17, 2012
|
| María Belén Pont Regulatory Country Manager- Argentina Bristol-Myers Squibb Argentina |
María Belén Pont has worked for BMS since January 2006. For the first two years, she worked as the Regulatory Area Coordinator, being mainly responsible for the implementation and operation of new products and line extension registration in Argentina. In October 2008, she was promoted to Regulatory Manager for Argentina and continues in this... more › |
11am Generics Congress: Wednesday, April 18, 2012
12pm Generics Congress: Wednesday, April 18, 2012
|
| Raquel Boy Professor of Pediatrics State University of Rio de Janeiro |
-Medical School at State University of Rio de Janeiro - UERJ -Fellow in Pediatrics and Medical Genetics at Fundação Oswaldo Cruz, Ministry of Health, Rio de Janeiro, Brazil -Master in Child Health and PhD in Public Health both at Fundação Oswaldo Cruz -Professor at Pediatrics Department, School of Medicine - UERJ -In charge of the Genetics Service ... more › |
1.40pm Drug Discovery: Wednesday, April 18, 2012
|
| Antonio Britto Executive President Interfarma |
more › |
3.35pm BioPharma: Tuesday, April 17, 2012
|
| Joao Calixto Departamento de Farmacologia Universidade Federal de Santa Catarina |
João B. Calixto received degree in Biological Sciences in 1973 at the University of Brasilia and then concluded his Master Science in Pharmacology by Federal University of São Paulo, (EPM) in 1976 and this PhD in Pharmacology in 2004, at the University of São Paulo, Brazil. He is currently professor of Pharmacology at the Federal University of... more › |
11am Drug Discovery: Wednesday, April 18, 2012
|
| Gabriela Cezar Senior Director & Head – Brazil, External R&D Innovation Pfizer Inc. |
more › |
9.30am Drug Discovery: Wednesday, April 18, 2012
|
| Marcelo Cheresky VP for Latin America, Japan and Asia Pacific Genzyme |
more › |
5.10pm Drug Discovery: Wednesday, April 18, 2012
|
| Carlos Correia Professor Campinas State University |
Carlos Roque Duarte Correia received his Bachelor’s degree in Pharmacy from the Federal University of Rio de Janeiro (UFRJ) in 1976 followed by a Master’s degree in Chemistry of Natural Products in 1980. In 1981 he was accepted at the graduate program at Stanford University, USA, where he got his PhD degree in Chemistry in 1986 under the... more › |
3.10pm Drug Discovery: Wednesday, April 18, 2012
|
| Rodrigo Crispim Associate Director, Regional Clinical Operations Brazil Bristol-Myers Squibb |
Rodrigo Crispim is the Brazil Regional Clinical Operations Hub Unit Manager with eight years of clinical research experience at Bristol-Myers Squibb. He worked as protocol manager in Lawrenceville, NJ for during the last 6 months from 2010 and previously managed the site monitoring team in Sao Paulo, Brazil for three years. Before that, he... more › |
2.30pm BioPharma: Tuesday, April 17, 2012
5.15pm BioPharma: Tuesday, April 17, 2012
|
| Paulo Roberto de Carvalho Technology Transfer Manager Universidade Estadual Paulista |
Bachelor with a degree in Chemistry (Unesp - Universidade Estadual Paulista, 1993), bachelor in Chemical Technology (Unesp, 1994), master's degree (Unesp, 1997) and doctorate in Chemistry (Unesp, 2002), in the area of Organic Chemistry, subarea Natural Products, with scientific interchange conducted within the University of Arizona, in... more › |
2.30pm BioPharma: Tuesday, April 17, 2012
4.50pm BioPharma: Tuesday, April 17, 2012
|
| Marcio de Paula Strategy Management Officer Biolab Sanus Farma |
Marcio de Paula is veterinarian with extensive experience on drug discovery/development, R&D project and strategic alliances/partnerships management. He currently holds the Strategy Management Officer position at Biolab Pharma. more › |
10am Drug Discovery: Wednesday, April 18, 2012
|
| Odnir Finotti Presidente Executivo ProGenericos |
Odnir Finotti is the Executive President and current CEO of ProGenericos. Mr. Finotti has been working in the pharmaceutical industry for over 30 years, including 15 years as CEO for multinational companies like ASTA Medica, Schering-Plough and Mepha Brasil. Founded in January 2001, the Brazilian Association of Generic Drugs - ProGenericos brings ... more › |
9am Generics Congress: Wednesday, April 18, 2012
10am Generics Congress: Wednesday, April 18, 2012
|
| Cristiano Funari Professor, Chemistry Institute UNESP |
Possui graduação em Engenharia Química pela Universidade Estadual de Campinas (1999), tendo obtido o grau de mestre em Fármaco e Medicamentos (Farmacognosia) pela Universidade de São Paulo - USP (2005) e doutorado em Química (Produtos Naturais) pelo Instituto de Química da Universidade Estadual Paulista - UNESP (2010). Realizou parte de seu... more › |
11.25am Drug Discovery: Wednesday, April 18, 2012
|
| Cecilia Gabarain Director, Area Clinical Quality Lead - Clinical Operations Pfizer |
Graduated in Biochemistry from University of Buenos Aires, Argentina, specialized in Biotechnology. Joined Pfizer in 2000 as a Clinical Research Associate and held positions of increasing responsibility within the monitoring area, was then appointed as a Clinical Monitoring Manager and later as Quality Standards & Process Implementation... more › |
9.30am Pharma Trials: Wednesday, April 18, 2012
|
| MD Pedro Garbes Regional Director, Clinical Development Sanofi Pasteur |
Pedro Garbes, M.D., has large experience in health education, healthcare, clinical epidemiology, scientific methodology, internal medicine, intensive care, evidence-based medicine, infectious diseases, clinical and epidemiological research including clinical trials (phase II to IV) in several therapeutic areas (infectious... more › |
4.10pm Pharma Trials: Wednesday, April 18, 2012
|
| Dr. Ajay Gautam Executive Director, Head, Emerging Markets Collaborations AstraZeneca |
Dr. Ajay Gautam is Executive Director and Head of Emerging Markets Collaborations for AstraZeneca where he is leading the development and implementation of AstraZeneca R&D’s strategy and collaborations in Emerging Markets. Prior to joining AstraZeneca, Ajay was the Co-founder and Managing Director of Bio-nAbler, a healthcare investment firm... more › |
8.50am Drug Discovery: Wednesday, April 18, 2012
|
| Derek Kosti Worldwide Biopharmaceutical Businesses Controller - International Pfizer |
Derek Kosti is the Worldwide Biopharmaceutical Business Controller - International for Pfizer Inc. In this role, Derek is responsible for ensuring the integrity of financial reporting, enhancing the control environment and reviewing all collaborative arrangements relating to Pfizer’s international operations. In addition, he assesses financial... more › |
9am BioPharma: Tuesday, April 17, 2012
1.05pm BioPharma: Tuesday, April 17, 2012
|
| Fernando Kreutz President FK Biotec |
more › |
9am Drug Discovery: Wednesday, April 18, 2012
|
| Laura Luchini Diretora da Unidade de Estudos Clínicos (CSU) Sanofi |
Dr. Laura Luchini is Clinical Study Unit Director at Sanofi Brazil and Coordinator and Professor of the Post-Graduation Program in Clinical Research at Santa Casa Medical School in Sao Paulo, Brazil. Dr Luchini counts +20 years of experience in epidemiologic and clinical investigation at both Academic and Pharmaceutical Industry settings. She... more › |
11.10am Pharma Trials: Wednesday, April 18, 2012
|
| Dr Eduardo Raul Mansilla Professor of Internal Medicine National University of La Plata, Argentina Director of the Regenerative Medicine, Tissue Engineering and Cell Therapies Laboratory CUCAIBA , Province of Buenos Aires, Ministry of Health, Argentina |
more › |
2.10pm Drug Discovery: Wednesday, April 18, 2012
|
| Fabio Mataveli Medical Director Brazil Janssen |
Fabio Mataveli holds a MD from the State University of Campinas (UNICAMP), a PhD in Gene Therapy from the Federal University of São Paulo (UNIFESP), a MBA in Finance from Fundação Getulio Vargas (FGV) and a Specialization in Health Economics from the State University of São Paulo (USP). Worked under a UNESCO contract position as Consultant in... more › |
1.05pm BioPharma: Tuesday, April 17, 2012
1.40pm Pharma Trials: Wednesday, April 18, 2012
|
| Weining Meng Senior Manager, International Business Department Sinovac |
Mr. Weining Meng is the senior manager of international marketing of Sinovac Biotech Co., Ltd, listed in Nasdaq as the code of “SVA”. Weining Meng has obtained the engineering bachelor from China Pharmaceutical University in 2001 and the science master degree from the University of Queensland. He has worked as an analyst in National Engineering... more › |
2.30pm BioPharma: Tuesday, April 17, 2012
4pm BioPharma: Tuesday, April 17, 2012
|
| Marco Miguel Marketing Director EMS |
Graduated in Economy at the University of São Luis, S.Paulo, post graduation in Marketing at the FGV and Business Management from Don Cabral Foundation. Broad knowledge in generics in Brazil, have been working in sales since the beginning of the generic.Participated in several important facts that mark the growth of generics in Brazil. more › |
3.40pm Generics Congress: Wednesday, April 18, 2012
|
| Andre Norio Yamada Medical Affairs Director Baxter |
||
| Pedro Palmeira Executive Director BNDES-AI/DEFARMA |
more › |
9.25am BioPharma: Tuesday, April 17, 2012
1.05pm BioPharma: Tuesday, April 17, 2012
|
| Maryet Perez Medical Director AstraZeneca |
I studied at Universidad Centro-Occidental “Lisandro Alvarado” (UCLA) and graduated as a physician in 1993. I obtained a specialization post degree in Internal Medicine in 1998 at the Universidad Central de Venezuela (UCV). As soon as I finished my specialization I started to work in Merck Sharp and Dohme, as Medical Services Manager and Clinical... more › |
11.40am BioPharma: Tuesday, April 17, 2012
|
| Mauricio Pinheiro Legal Director AstraZeneca |
Mauricio Joffily Pereira da Costa Pinheiro is graduated in Law at PUC/SP (Catholic University of São Paulo – Brazil), with specialization in Intellectual Property and Tax and post-graduating degree in business management from FGV. Mauricio is currently at the Legal Dept of AstraZeneca Brazil as associate legal director. Before joining AZ, he... more › |
1.40pm BioPharma: Tuesday, April 17, 2012
|
| Felipe Pinho Medical Director EMS |
more › |
2.30pm BioPharma: Tuesday, April 17, 2012
9.30am Generics Congress: Wednesday, April 18, 2012
10am Generics Congress: Wednesday, April 18, 2012
|
| Juan Manuel Pinto-Ribeiro Correa Brazilian Director ProMexico |
Experiencias en diferentes mercados / segmentos, tales como bebidas, cosméticos, alimentos, productos infantiles y medicamentos “populares (OTC’s”), habiendo vivido en México, Estados Unidos y Brasil. Participé y comandé varias actividades de reorganización empresarial debido a condiciones de mercado, fusiones y adquisiciones, administrando... more › |
2.30pm BioPharma: Tuesday, April 17, 2012
|
| Vinzenz Plorer Vice President , Operations EMS Brazil |
Vinzenz Plorer is Vice President Operations at EMS Pharma in charge of unbranded generics business, branded generics business, hospital business and international business. EMS is the leading pharmaceutical company in Brazil with around 10% market share of the total pharmaceutical market and 30% in generics. Vinzenz is counseling member of... more › |
4.25pm BioPharma: Tuesday, April 17, 2012
|
| Maria Claudia Pontes LATAM Gnx Platform Sanofi aventis |
more › |
1.40pm Generics Congress: Wednesday, April 18, 2012
|
| Luis Russo Director APCB - Investigators Society |
Médico Pesquisador e CEO do CCBR Brasil Centro de Análises e Pesquisas Clínicas há 10 anos no mercado com mais de 40 estudos multicentricos conduzidos para as grandes multinacionais. Temos unidades no Rio e S Paulo com caracteristicas de multiespecialidades, ous seja conduzimos estudos em varias areas das doenças cronicas e degenerativas como... more › |
10am Pharma Trials: Wednesday, April 18, 2012
11.35am Pharma Trials: Wednesday, April 18, 2012
4.10pm Pharma Trials: Wednesday, April 18, 2012
|
| Mariana Sandroni Coordinator IPD-Farma |
Possui graduação em Ciências Biológicas pela Universidade do Estado do Rio de Janeiro, mestrado em Genética Molecular Vegetal pela Universidade Federal do Rio de Janeiro e pós em Gestão Ambiental pela Coppe/UFRJ. Tem experiência em pesquisa e desenvolvimento de fármacos e prospecção de negócios (Nortec Química), pesquisa de opinião (Projeto... more › |
1.05pm BioPharma: Tuesday, April 17, 2012
|
| Diego Santoro Regional Portfolio Head Sandoz |
more › |
2.10pm Generics Congress: Wednesday, April 18, 2012
|
| Marcio Silva Branded Generics Regulatory Manager GlaxoSmithKline |
Pharmacist, male, 33 years old, Regulatory Manager at GSK based in Rio de Janeiro, Brazil. Currently responsible for all Branded Generics and Generics Regulatory activities of GSK in Brazil. I have been also supporting a couple of local Business Development initiatives including local and international partnership and products... more › |
11.30am Generics Congress: Wednesday, April 18, 2012
12pm Generics Congress: Wednesday, April 18, 2012
|
| Samuel Silva Director of Research and Inovation Cristalia Prod. Quim. Farm. Ltda |
Samuel Silva, PhD has several years of experience in the pharmaceutical research and development field. Dr. Silva Currently heads the R&D operations at Cristalia Quimica & Farmaceutica in Sao Paulo, Brazil, in this position he is responsible for providing strategic and scientific leadership for all activities within the R&D division. He is... more › |
4.40pm Drug Discovery: Wednesday, April 18, 2012
|
| Eduardo Sousa Professor Federal University of Ceará |
Dr Sousa earned his bachelor degree in Chemistry (1998), Masters(2000) and Doctoral in Chemistry (2003) at the Federal University of Ceará(Brazil) working with bioinorganic chemistry. In 2001, he spent time doing research at the San Francisco State University (San Francisco, USA) working with soluble guanylate cyclase (nitric oxide receptor). In... more › |
4.10pm Drug Discovery: Wednesday, April 18, 2012
|
| Dr. Helder Souza Healthcare Solutions & Project Manager - LATAM Siemens Healthcare Diagnostics |
PhD Degree in Production Engineering focused on Project Management at Sao Paulo State University (UNESP), Master Degree in Science & Electrical Engineering with emphasis in Control & Industrial Automation at Federal University of Itajubá (UNIFEI), MBA at Getulio Vargas Foundation (FGV), Post-graduated in Project Management at University of São... more › |
3.40pm Drug Discovery: Wednesday, April 18, 2012
|
Register for World Pharma Trials Congress LatAm 2012 »
Download the brochure »